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Background: The role for the private sector in health remains subject to much debate, especially within the
context of achieving universal health coverage.
This roundtable discussion offers diverse perspectives from a range of stakeholders – a health funder, a
representative from an implementing organization, a national-level policy-maker, and an expert working in a large
multi-national company – on what the future may hold for the private sector in health.
Discussion: The first perspective comes from a health funder, who argues that the discussion about the future role
of the private sector has been bogged down in language. He argues for a ‘both/and’ approach rather than an
‘either/or’ when it comes to talking about health service provision in low- and middle-income countries.
The second perspective is offered by an implementer of health insurance in sub-Saharan Africa. The piece examines
the comparative roles of public sector actors, private sector actors and funding agencies, suggesting that they must
work together to mobilize domestic resources to fund and deliver health services in the longer term.
Thirdly, a special advisor working in the federal government of Nigeria considers the situation in that country. He
notes that the private sector plays a significant role in funding and delivering health services there, and that the
government must engage the private sector or forever be left behind.
Finally, a representative from a multi-national pharmaceutical corporation gives an overview of global shifts that are
creating opportunities for the private sector in health markets.
Summary: Overall, the roundtable discussants agree that the private sector will play an important role in future
health systems. But we must agree a common language, work together, and identify key issues and gaps that
might be more effectively filled by the private sector.Background
The role for the private sector in health remains subject
to much debate, especially within the context of achiev-
ing universal health coverage (UHC).
One of the reasons this debate remains so vibrant is
the diversity of actors encapsulated in the term ‘private
sector’. As Mills (2002) notes, the private sector in health
comprises of ‘all providers who exist outside the public
sector, whether their aim is philanthropic or commercial,
and whose aim is to treat illness or prevent disease’ [1].
Participating in local, national and international health
markets, the private sector in low- and middle-income
countries ranges from informal medical practitioners and* Correspondence: j.knezovich@ids.ac.uk
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article, unless otherwise stated.druggists to national and multi-national companies as well
as non-governmental organizations (NGOs). Some of
these actors are more motivated by service to the public
good, while others have profit and efficiency firmly in their
sights. Though these issues are not necessarily mutually
exclusive, they strongly affect the types of products and
services provided, the target populations for them, and
their quality.
Another reason for this debate stems from the mul-
tiple and complex processes implicated in achieving
UHC. While the overarching aim of UHC is to ensure
that everyone has access to affordable and quality health
products and services regardless of background, in prac-
tice this requires strengthening health financing for, and
service provision of, an agreed package of basic health
services across a broad population. Yet there remains no
blueprint for how this might be achieved.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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Stallworthy et al. Globalization and Health 2014, 10:55 Page 2 of 5
http://www.globalizationandhealth.com/content/10/1/55In this roundtable discussion, we present short opinion
pieces from a range of relevant stakeholders offering di-
verse views about this complex issue. Though the com-
ments offer suggestions on where the private sector has
a complementary role to play in both health financing
and on healthcare provision, we have not sought to es-
tablish an agreed view. The arguments put forward by
individual commentators in this discussion are not ne-
cessarily accepted by, and may even be contradicted by,
authors of other sections.
We start with a framing piece from a representative of
one of the world’s largest health funders that argues that
interest groups are talking past each other because they
don’t share a common language. We then move on to
a piece looking at the comparative roles of funders,
policy-makers and private sector health funders and
how they can work together. A national-level policy-
maker then argues that the private sector in health is
often vibrant, and that governments, therefore, must
engage with these players or risk being left behind.
Finally, a representative from a multinational pharma-
ceutical company addresses some of the opportunities
and challenges for the private sector in health, focus-
ing mainly on sub-Saharan Africa.
Finding a common language
Guy Stallworthy, Senior Program Officer, Bill & Melinda
Gates Foundation (http://www.gatesfoundation.org/).
Some people are uncomfortable using the language of
markets when it comes to health. Many are acutely aware
of the negative effects of market forces in health; acknow-
ledgement of health as a right is taken to imply that the
state has a duty to not only ensure access to healthcare
but to provide it; financing, regulation and provision are
often conflated; and public provider organizations consti-
tute a vested interest in this respect. There is a strong
preference, particularly at country level, to use the lan-
guage of health systems – and subsystems – and system
dynamics. On the other hand, systems thinking can be
applied in ways that suggest degrees of linearity and
managerial control that often do not apply. Concepts of
“complex adaptive systems” correct for this.
Both kinds of language are accurate and useful. The
language of markets draws attention to the fact that pa-
tients and citizens are also agents or consumers who ex-
ercise choices among sources and types of healthcare,
that public and private providers are all motivated by a
range of financial and non-financial incentives inherent
in all provider payment systems, that laws of supply and
demand apply. The benefits of both systems and market
thinking can be combined when we think about health-
care as a function of complex adaptive market systems.
It is also well recognized that markets for health have
particular characteristics that, while not unique to health,combine in a particular way. Information asymmetry is
more acute in health transactions than in the market for,
say, shoes. Barriers to entry, both regulatory and due to
economies of scale, distort many health markets. To ac-
knowledge that healthcare can be usefully understood as a
market system is not to suggest that the market for
healthcare is somehow “perfect”, still less that it results in
socially acceptable outcomes in the absence of state inter-
vention. On the contrary, most people acknowledge that
socially acceptable health outcomes never occur without
strong state action in the healthcare market, in financing,
regulation and provision. A desire to use market concepts
to improve equity in primary health care does not negate
the need for governments to intervene in markets to en-
sure that they have more equitable outcomes than they do
at present. It needn’t imply a desire to “promote” the pri-
vate sector or to “privatize” health.
The Bill & Melinda Gates Foundation has been com-
fortable talking about global markets for some time in
relation to specific technologies (vaccines, drugs, diag-
nostics, devices, vector-control products), and has been
working to shape health markets for these technologies
at the global level. The Foundation is also applying
the concept of markets at country level – in Ethiopia,
Nigeria, and in the northern states of India – to con-
tribute to better primary health care. And it is at this
level that the language begins to diverge.
However, there seems to be nothing incompatible
about viewing health-care delivery as a mixed public/pri-
vate market in which non-state actors are better placed
to deliver some services and, at the same time, uphold-
ing the state’s ultimate responsibility for the health of its
citizens.
Equally, there seems to be no inherent contradiction
between seeing health as a market and, at the same time,
recognizing that public finance needs to increase in both
absolute terms and as a proportion of the total resources
available for health. It is possible to separate finance from
provision. There is consensus, for example, that collective,
public or mandatory funding is the most equitable and ef-
ficient way to finance health care.
We can see the problems inherent in market-based
private provision, but we also recognize the strengths of
private players and markets and the dynamism presented
by private markets.
Most importantly, in order to be comfortable using
concepts, frameworks and analytical tools from markets
we do not have to idealize market outcomes; to have re-
spect for market forces is not to worship them but to
use them as and when appropriate to achieve public pol-
icy goals.
We need to find a way to communicate about these is-
sues, developing a language that enables us all to talk
without discomfort and without alienating those who fall
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holders to come together to discuss these issues is an
important next step.
Development partners or domestic resource
mobilization?
Kwasi Boahene, Director of Advocacy & Program De-
velopment at the Health Insurance Fund (http://www.
hifund.org/).
Healthcare is a public good and governments have a
responsibility to ensure its equitable provision. Yet in
most countries in sub-Saharan Africa, those on higher
incomes are more likely to have access to public-sector
health services than the poorest people. Only 25% of the
region’s population has access to any kind of quality
health care. The reasons include: lack of investments,
low public spending and limited inclusive mechanisms
for pooling risks and resources. Current health expend-
iture per capita, for example, is standing at just $93 per
year [2], compared to a developed-country (OECD) aver-
age of more than $3,400 [3].
We need a vision for effective health markets that re-
flects supply and demand as well as the choices made by
citizens, and that minimizes the financial risks to protect
both consumers and suppliers. And to achieve such a
vision, governments and donors must address public
spending, stimulate private investments and promote
improvement in healthcare quality.
One fundamental challenge is that universal health
coverage (UHC) has not been an integral part of govern-
ment policies to stimulate a strong public—private part-
nership (PPP) for mobilizing and ensuring efficient use
of resources, promoting improved delivery systems and
developing local business models.
The Health Insurance Fund, a donor funded initiative
working across Africa to ensure access to better quality
care for low-paid and previously uninsured workers, is
leveraging funding from a number of sources to address
this challenge. The Fund has been building communities
of practice – an area that requires investment in capacity-
building, policy-making, research, and the development of
local business models.
In Nigeria for example, the Fund has brought together
local policy-makers, NGOs and other private sector
actors to develop a health-care finance plan that will
mobilize domestic resources. This has been a prime ex-
ample of risk-sharing to ensure that poor people have ac-
cess to good quality care while, at the same time, ensuring
that health investment is worthwhile for private providers.
In Lagos, the Health Insurance Fund’s subsidized health
care for market women and petty traders of consumer
electronics has transitioned into a non-subsidized product.
In Nigeria’s Kwara state, the state government pays about
60% of the premium while the co-premium of participantshas almost doubled. Private providers earn enough in-
come from the premium to enable them to invest in qual-
ity and facilities.
Initiatives like this show that the development of health
markets need not be over-reliant on development partners
in the long-term. While donor funding is useful to lever-
age additional resources, the long-term priority must be
to build strong domestic institutions that can mobilize do-
mestic funds and, with the support of the private sector,
use these funds wisely.
Governments must intervene in health markets now or
forever be playing catch up
Kelechi Ohiri, Senior Special Advisor to the Minister of
State for Health in Nigeria (http://www.nigeria.gov.ng/).
Nigeria’s efforts to address health-market constraints
provide pointers for policy-makers elsewhere. One key
constraint has been the country’s complexity, with its
devolved states running mini health-care markets and
systems across 774 local government authorities and al-
most 10,000 wards. Health care is the responsibility of
every tier of government: the risk being that if health
care is everyone’s responsibility, it may become nobody’s
responsibility.
The results of a recent review of Nigeria’s health mar-
kets [4] have been sobering. Drawing on consultation
across the health-care space – private as well as public –
the review revealed a system that was fragmented and
under-performing, with sub-optimal outcomes and poor
quality services that accentuated inequities. The lack of
protection from financial risk undermined demand,
health insurance coverage was minimal and most pay-
ments were out of pocket. The review also found that
the private sector accounted for around half of all
health-care provision. Clearly, it was time to stop view-
ing the health market as purely ‘public sector’, and
recognize its mix of public and private provision. The
reality, however, is that the level of engagement with the
private sector was minimal, and more needed to be done
to bring private players into the healthcare discourse.
As the country embarks on its aspiration toward UHC
and expanding access to the poor, models of engaging the
private sector – through PPPs and other mechanisms –
become important for the government. In doing so, the
government needs to ensure that the right governance
structures are in place to ensure that equity of access to
care is preserved and costs are effectively managed.
The Government aims to respond to this reality now,
rather than play catch-up later. In addition to the study,
the Government convened the first Private Health Sum-
mit with over 150 private health sector leaders and
followed up with the establishment of a Joint Steering
Task Force on Unlocking the Market Potential of the
Private Health Sector. The results of these engagements
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areas:
1. The review of fiscal policy (such as tariffs and
import duties) that impact the health sector.
2. The improvement of regulatory frameworks
through, for example, quality accreditation and
standards of care.
3. Improving access to finance for healthcare
investments.
4. The development of different PPP models.
5. The engagement of the private sector, beyond
health, in improving access to health services.
The health sector now has a seat on Nigeria’s highest
policy-making body – the Economic Management Team –
and the country is developing performance-based finan-
cing mechanisms linked to disbursements. The ‘Save
One Million Lives’ initiative (http://www.soml.org.ng/)
uses scorecards to hold federal entities accountable for
health outcomes. The Government has also set up a
Ministerial Committee on Universal Health Coverage
to explore options for the country as we move forward.
Finally, the Government is also exploring how labor-
market dynamics could attract the Nigerian diaspora to fill
human-resource gaps.
The aim is to move away from ideology to focus on
what works, backed by solid research and data on health
markets.
The view from ‘big business’
Allan Pamba, Director Public Engagement and Access
Initiatives at GlaxoSmithKline (http://www.gsk.com/).
Given the changing business landscape, multinational
companies are exploring their potential role in health mar-
kets, particularly in sub-Saharan Africa. Africa is moving
up their agenda and is now seen as a region that requires
robust corporate strategies. This is because Africa is now
viewed as the ‘final frontier’ for business growth and com-
panies are aware that if they are to thrive there in the
coming decades, they must get in today.
There are, however, three key challenges.
First, we need a cultural shift on the ‘acceptable’ role of
the private sector in health markets beyond trade or
donations. We require genuine partnerships that play
to the strengths of each partner – public or private –
in developing and delivering solutions.
Second, we need alignment on the key gaps/priorities.
Consensus will not be easy, given the number of
players involved, but it is essential.
Third, healthcare is low on the agenda of many
developing countries. In Africa only a handful of
countries have reached the Abuja Declaration target of15% of GDP spent on health. Without such investment,
governments will find it hard to shape effective health
markets.
There are, however, opportunities. The first, paradoxic-
ally, is the global economic downturn, which has created a
gap in NGO health funding. This is driving greater scru-
tiny of existing projects, weeding out initiatives that don’t
deliver and opening a potential niche for private sector
participation.
Second, Africa’s growing middle class is an attractive
market for the private sector. There is the growing appe-
tite for African strategies in multinational companies that
have real international ‘muscle’. The annual turnover of
the top five pharmaceutical companies [5], for example, is
equivalent to nearly one quarter of sub-Saharan Africa’s
total GDP [6].
Third, the rising incidence of non-communicable dis-
eases, like diabetes and hypertension, in Africa presents
an interesting opportunity for the private sector; many
solutions have already been developed in high-income
countries and the private sector could be the bridge to
carry them into low-income countries, repurposing them
for local contexts.
Finally, we have new technology and innovations emer-
ging that can help leapfrog progress and shape future
health markets.
Maximizing these opportunities requires strong leader-
ship to ensure that future markets give more people ac-
cess to better health care sooner, rather than later. Next
steps include the sharper framing of the health gaps to
be addressed and finding good partners to plug these
gaps, advocacy to raise the profile of health and greater
support for health innovations that are emerging from
Africa itself.
Summary
Overall, the roundtable discussants agree that the pri-
vate sector will play an important role in future health
systems and in achieving UHC. However, the exact nature
of the role that private sector actors might play is far from
certain. Some are keen to see the role of the private sector
grow, while others see working with the private sector as a
pragmatic necessity in a government-dominated system.
Some see the role for the private sector as focusing on ser-
vice provision, while others see a distinct role for private
financing. But we must agree a common language, work
together, and identify key issues and gaps that might be
more effectively filled by both the public and private sec-
tors in order to achieve UHC.Abbreviations
UHC: Universal health coverage; NGO: Non-governmental organization;
PPP: Public—private partnership; GDP: Gross domestic product.
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